Abstract
Gene therapy may become a powerful therapeutic strategy. However, the application of this method in the treatment of ocular disease presents us with interesting and unique questions. Gene therapy for ocular inflammatory disease has the potential for both therapeutic interventions and a method for studying mechanisms of disease. An evolving philosophy on this subject would support the use of somatic gene therapy for ocular inflammatory disease, even if not life threatening. Major technical questions remain, including the use of the appropriate vector, the best methodology for the stable insertion into the genome, and the duration and intensity of expression of the transgene. Various transgenes encoding a wide variety of proteins can be envisaged for the insertion of genes. The study of gyrate atrophy, an hereditary ocular disorder and an excellent candidate for gene therapy, has given us enormous information in the development of practical therapeutic strategies, as have in vitro studies of gene insertion. Future concerns will need to concentrate on the use of better methods for gene insertion and homologous recombination techniques for the development of animal models and later as a strategy for gene therapy. The use of gene therapy as a drug delivery system must also be considered. In addition, the elucidation of the various events controlling transcription for the expression of transgenes in various resident ocular cells is necessary.
Similar content being viewed by others
Article PDF
References
Wang T, Milam AH, Steel G, Valle D . A mouse model of gyrate atrophy of the choroid and retina. J Clin Invest 1996;97:2753–62.
Kozarsky KF, Wilson JM . Gene therapy: adenovirus vectors. Curr Opin Genet Dev 1993;3:499–503.
Engelhardt JF, Ye X, Doranz B, Wilson JM . Ablation of E2A in recombinant adenoviruses improves trans-gene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 1994;91:6196–200.
Morgan RA, Anderson WF . Human gene therapy. Annu Rev Biochem 1993;62:191–217.
Cornetta K, Morgan RA, Anderson WF . Safety issues related to retroviral-mediated gene transfer in humans. Hum Gene Ther 1991;2:5–14.
Kaiser-Kupfer M, Caruso R, Valle D . Gyrate atrophy of the choroid and retina: chronic reduction of ornithine slows retinal degeneration. Arch Ophthalmol 1991;109:1539–48.
Vogel JC . Keratinocyte gene therapy. Arch Dermatol 1993;129:1478–83.
Sullivan DM, Chung DC, Anglade E, Nussenblatt RB, Csaky KG . Adenovirus-mediated gene transfer of ornithine aminotransferase in cultured human retinal pigment epithelium. Invest Ophthalmol Vis Sci 1996;37:766–74.
Bennett J, Wilson J, Sun D, Forbes B, Maguire A . Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest Ophthalmol Vis Sci 1994;35:2535–42.
Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA . Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189–92.
Tombran-Tink J, Chader GG, Johnson LV . PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 1991;53:411–4.
Unoki K, LaVail MM . Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest Ophthalmol Vis Sci 1994;35:907–15.
Blau HM, Springer ML . Gene therapy: a novel form of drug therapy. N Engl J Med 1995;333:1204–7.
Papavassiliou AG . Transcription factors. N Engl J Med 1995;332:45–7.
Egwuagu CE, Sztein J, Reid W, et al. Gamma interferon gene expression in the lens of transgenic mice directed by the alpha-A-crystallin gene promoter. Invest Ophthalmol Vis Sci 1992;33:846.
Egwuagu CE, Sztein J, Chan CC, et al. Gamma interferon expression disrupts lens and retinal differentiation in transgenic mice. Dev Biol 1994;166:557–68.
Egwuagu CE, Mahdi R, Smith JA, Chan CC, Chepelinsky AB . Gamma interferon-expressing transgenic rats: a useful model of anterior and posterior uveitis. Invest Ophthalmol Vis Sci 1996;37(Suppl):4229.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nussenblatt, R., Csaky, K. Perspectives on gene therapy in the treatment of ocular inflammation. Eye 11, 217–221 (1997). https://doi.org/10.1038/eye.1997.55
Issue Date:
DOI: https://doi.org/10.1038/eye.1997.55
Keywords
This article is cited by
-
Gene therapy in the treatment of ocular inflammation
Springer Seminars in Immunopathology (1999)